| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Immunome, Inc. (IMNM) have been net sellers, shedding 111,912 shares worth roughly $2.9M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 870.7K | $17.68M | - | |
| Dir | 341.1K | $6.93M | - | |
| CFO | 101.3K | $2.06M | - | |
| Dir | 92.2K | $1.87M | - | |
| Other | 81.5K | $1.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 | Michael Rapp | Director | Buy | 45,950 | $18.07 | $830,448.60 | +33.6% | -9.1% | -71.3% | |
| May 26, 2021 | Michael Rapp | Director | Buy | 53,498 | $18.38 | $983,423.06 | +64.2% | -29.8% | -83.4% | |
| May 26, 2021 | Michael Lefenfeld | Director | Buy | 4,650 | $18.53 | $86,149.65 | +20.9% | -29.8% | -83.4% | |
| May 25, 2021 | Purnanand D Sarma | President and CEO | Buy | 10,500 | $18.41 | $193,305.00 | New | -24.2% | -83.8% | |
| May 24, 2021 | John L Lamattina | Director | Buy | 5,440 | $18.57 | $101,027.88 | +11.7% | -23.5% | -81.7% | |
| May 24, 2021 | Philip Wagenheim | Director | Buy | 13,500 | $18.35 | $247,725.00 | +3.5% | -23.5% | -81.7% | |
| Oct 6, 2020 | Michael Rapp | Director | Buy | 83,332 | $12.00 | $999,984.00 | +15.0% | - | - |